Orrick Herrington & Sutcliffe advised HCW Biologics on the deal while Sheppard Mullin advised the underwriters. HCW Biologics Inc. (NASDAQ:HCWB) has announced that it is launching…
HCW Biologics’ $56 Million IPO


Orrick Herrington & Sutcliffe advised HCW Biologics on the deal while Sheppard Mullin advised the underwriters. HCW Biologics Inc. (NASDAQ:HCWB) has announced that it is launching…
…